Skip to main content
SpringerLink
Log in

Is Ondansetron Cost Effective?

  • Current Comment
  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Seynave C, Schuller J, Buser K, et al. Comparison of the antiemetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in accute cisplatin-induced emesis. A multicentric, double-blind, randomized parallel group study. Br J Cancer 1992; 66: 192–7

    Article  Google Scholar 

  2. Ploskcr GL, Milne RJ. Ondansetron: a pharmacoeconomic and quality of life evaluation of its antiemetic activity in patients receiving carcer chemotherapy. PharmacoEconomics 1992; 2: 285–304

    Article  Google Scholar 

  3. Sookop M, McQuade B, Hunter E, et al. Ondansetron compared with metoclopnmide in the, control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 1992; 49: 295–304

    Article  Google Scholar 

  4. Cunningham D, Gore M, Davidson N, et al. The real cost of emesis. An eronomic analysis of ondansctron vs metoclopramide in controlling emesis in patients receiving chemotherapy for cancer. Eur J Cancer 1993; 29A: 303–6

    Article  PubMed  CAS  Google Scholar 

  5. Buxton MJ, O’Brien RJ. Economic evaluation of ondansesetron preliminary analysis using clinical trial data prior to Price setting. Sr J Cancer 1992; 66: 564–7

    Google Scholar 

  6. Jones AL, Lee GJ, Bosanquet N. The budgetary impact or 5HT-3 receptor antagonists in the management of chemotherapy induced emesis. Eur J Cancer 1993; 29A: 51–6

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre Oscar Lambret, 1 rue Frederic Combenale, Lille, 59020, France

    Jacques Bonneterre

Authors
  1. Jacques Bonneterre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonneterre, J. Is Ondansetron Cost Effective?. Pharmacoeconomics 6, 581–583 (1994). https://doi.org/10.2165/00019053-199406060-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199406060-00011

Keywords

Search

Navigation